Fig. 7From: Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresisLeft Pannel shows CT Scan at diagnosis of chronic lung GVHD. Right panel shows CT scan 3 months after ruxolitinb treatmentBack to article page